Form D · Other Health Care
Carson Laboratories, Inc.
Carson, CA · CIK 0001495458
Offering snapshot reported Jun 28, 2010 · SEC filing
- Reported sold
- $340K Offering amount: $700K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jun 14, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 28, 2010 | Initial | $340,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 05
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-144124
Source: Form D, filed Jun 28, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael John Arnold | Director, Executive |
| John Paul Geissbauer | Director |
| Allan Brown Jaynes | Director |
| Gary Ed Le Grand | Director |
| Greg Jay Vigoren | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
20850 Leapwood Drive Suite G
Carson, CA, 90746
Carson, CA, 90746